PRMT4 blocks myeloid differentiation by assembling a Methyl-RUNX1-dependent repressor complex

Cell Reports

Volumn 5, Issue 6, 2013, Pages 1625-1638

  Vu, Ly P ^a,b   Perna, Fabiana ^a   Wang, Lan ^a,c   Voza, Francesca ^a   Figueroa, Maria E ^d   Tempst, Paul ^a   Erdjument Bromage, Hediye ^a   Gao, Rui ^e   Chen, Sisi ^e   Paietta, Elisabeth ^f   Deblasio, Tony ^a   Melnick, Ari ^g   Liu, Yan ^e   Zhao, Xinyang ^a,h   Nimer, Stephen D ^a,b,c,i  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Gerstner Sloan Kettering Graduate School of Biomedical Sciences   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ALBERT EINSTEIN CANCER CENTER   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD34 ANTIGEN; CELL PROTEIN; DOUBLE PHD FINGER 2; MESSENGER RNA; MICRORNA 223; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 4; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLAST CELL; BONE MARROW CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; COMPLEX FORMATION; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEPLETION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY SEQUENCE; TRANSCRIPTION REGULATION; TUMOR VOLUME; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; EPIGENETIC REPRESSION; HEMATOPOIESIS; HUMANS; METHYLATION; MICE; MICRORNAS; MYELOID PROGENITOR CELLS; PROTEIN BINDING; PROTEIN-ARGININE N-METHYLTRANSFERASES; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 84891008290     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.11.025     Document Type: Article

References (42)

1. An W., Kim J., Roeder R.G. Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 2004, 117:735-748.
2. Bedford M.T., Clarke S.G. Protein arginine methylation in mammals: who, what, and why. Mol. Cell 2009, 33:1-13.
3. Blyth K., Cameron E.R., Neil J.C. The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer 2005, 5:376-387.
4. Chen S.L., Loffler K.A., Chen D., Stallcup M.R., Muscat G.E.O. The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2. J.Biol. Chem. 2002, 277:4324-4333.
5. Cheung N., Chan L.C., Thompson A., Cleary M.L., So C.W.E. Protein arginine-methyltransferase-dependent oncogenesis. Nat. Cell Biol. 2007, 9:1208-1215.
6. Cheung W.D., Sakabe K., Housley M.P., Dias W.B., Hart G.W. O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. J.Biol. Chem. 2008, 283:33935-33941.
7. Covic M., Hassa P.O., Saccani S., Buerki C., Meier N.I., Lombardi C., Imhof R., Bedford M.T., Natoli G., Hottiger M.O. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J. 2005, 24:85-96.
8. Daujat S., Bauer U.-M., Shah V., Turner B., Berger S., Kouzarides T. Crosstalk between CARM1 methylation and CBP acetylation on histone H3. Curr. Biol. 2002, 12:2090-2097.
9. Eulalio A., Huntzinger E., Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 2008, 132:9-14.
10. Eyholzer M., Schmid S., Schardt J.A., Haefliger S., Mueller B.U., Pabst T. Complexity of miR-223 regulation by CEBPA in human AML. Leuk. Res. 2010, 34:672-676.
11. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA 2007, 104:15805-15810.
12. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., Bozzoni I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123:819-831.
13. Fazi F., Racanicchi S., Zardo G., Starnes L.M., Mancini M., Travaglini L., Diverio D., Ammatuna E., Cimino G., Lo-Coco F., et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007, 12:457-466.
14. Figueroa M.E., Abdel-Wahab O., Lu C., Ward P.S., Patel J., Shih A., Li Y., Bhagwat N., Vasanthakumar A., Fernandez H.F., et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010, 18:553-567.
15. Fontana L., Pelosi E., Greco P., Racanicchi S., Testa U., Liuzzi F., Croce C.M., Brunetti E., Grignani F., Peschle C. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat. Cell Biol. 2007, 9:775-787.
16. Fukao T., Fukuda Y., Kiga K., Sharif J., Hino K., Enomoto Y., Kawamura A., Nakamura K., Takeuchi T., Tanabe M. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 2007, 129:617-631.
17. Garzon R., Liu S., Fabbri M., Liu Z., Heaphy C.E.A., Callegari E., Schwind S., Pang J., Yu J., Muthusamy N., et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009, 113:6411-6418.
18. Grimson A., Farh K.K.-H., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27:91-105.
19. Higashimoto K., Kuhn P., Desai D., Cheng X., Xu W. Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1. Proc. Natl. Acad. Sci. USA 2007, 104:12318-12323.
20. Ho L., Ronan J.L., Wu J., Staahl B.T., Chen L., Kuo A., Lessard J., Nesvizhskii A.I., Ranish J., Crabtree G.R. An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc. Natl. Acad. Sci. USA 2009, 106:5181-5186.
21. Johnnidis J.B., Harris M.H., Wheeler R.T., Stehling-Sun S., Lam M.H., Kirak O., Brummelkamp T.R., Fleming M.D., Camargo F.D. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129.
22. Kim J., Lee J., Yadav N., Wu Q., Carter C., Richard S., Richie E., Bedford M.T. Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early Tcell development. J.Biol. Chem. 2004, 279:25339-25344.
23. Koh S.S., Li H., Lee Y.-H., Widelitz R.B., Chuong C.-M., Stallcup M.R. Synergistic coactivator function by coactivator-associated arginine methyltransferase (CARM) 1 and β-catenin with two different classes of DNA-binding transcriptional activators. J.Biol. Chem. 2002, 277:26031-26035.
24. Kowenz-Leutz E., Pless O., Dittmar G., Knoblich M., Leutz A. Crosstalk between C/EBPbeta phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code. EMBO J. 2010, 29:1105-1115.
25. Lee Y.-H., Bedford M.T., Stallcup M.R. Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylation. Genes Dev. 2011, 25:176-188.
26. Liu F., Zhao X., Perna F., Wang L., Koppikar P., Abdel-Wahab O., Harr M.W., Levine R.L., Xu H., Tefferi A., et al. JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. Cancer Cell 2011, 19:283-294.
27. Matsuyama R., Takada I., Yokoyama A., Fujiyma-Nakamura S., Tsuji N., Kitagawa H., Fujiki R., Kim M., Kouzu-Fujita M., Yano T., Kato S. Double PHD fingers protein DPF2 recognizes acetylated histones and suppresses the function of estrogen-related receptor α through histone deacetylase 1. J.Biol. Chem. 2010, 285:18166-18176.
28. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996, 84:321-330.
29. Osato M. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Oncogene 2004, 23:4284-4296.
30. Pulikkan J.A., Dengler V., Peramangalam P.S., Peer Zada A.A., Müller-Tidow C., Bohlander S.K., Tenen D.G., Behre G. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115:1768-1778.
31. Rosenauer A., Raelson J.V., Nervi C., Eydoux P., DeBlasio A., Miller W.H. Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines. Blood 1996, 88:2671-2682.
32. Schurter B.T., Koh S.S., Chen D., Bunick G.J., Harp J.M., Hanson B.L., Henschen-Edman A., Mackay D.R., Stallcup M.R., Aswad D.W. Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry 2001, 40:5747-5756.
33. Song W.-J., Sullivan M.G., Legare R.D., Hutchings S., Tan X., Kufrin D., Ratajczak J., Resende I.C., Haworth C., Hock R., et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 1999, 23:166-175.
34. Torres-Padilla M.-E., Parfitt D.-E., Kouzarides T., Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 2007, 445:214-218.
35. Varambally S., Cao Q., Mani R.-S., Shankar S., Wang X., Ateeq B., Laxman B., Cao X., Jing X., Ramnarayanan K., et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008, 322:1695-1699.
36. Wang L., Huang G., Zhao X., Hatlen M.A., Vu L., Liu F., Nimer S.D. Post-translational modifications of Runx1 regulate its activity in the cell. Blood Cells Mol. Dis. 2009, 43:30-34.
37. Wang L., Gural A., Sun X.-J., Zhao X., Perna F., Huang G., Hatlen M.A., Vu L., Liu F., Xu H., et al. The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science 2011, 333:765-769.
38. Wu Q., Bruce A.W., Jedrusik A., Ellis P.D., Andrews R.M., Langford C.F., Glover D.M., Zernicka-Goetz M. CARM1 is required in embryonic stem cells to maintain pluripotency and resist differentiation. Stem Cells 2009, 27:2637-2645.
39. Xu W., Chen H., Du K., Asahara H., Tini M., Emerson B.M., Montminy M., Evans R.M. A transcriptional switch mediated by cofactor methylation. Science 2001, 294:2507-2511.
40. Yadav N., Cheng D., Richard S., Morel M., Iyer V.R., Aldaz C.M., Bedford M.T. CARM1 promotes adipocyte differentiation by coactivating PPARgamma. EMBO Rep. 2008, 9:193-198.
41. Yan M., Kanbe E., Peterson L.F., Boyapati A., Miao Y., Wang Y., Chen I.M., Chen Z., Rowley J.D., Willman C.L., Zhang D.E. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat. Med. 2006, 12:945-949.
42. Zhao X., Jankovic V., Gural A., Huang G., Pardanani A., Menendez S., Zhang J., Dunne R., Xiao A., Erdjument-Bromage H., et al. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev. 2008, 22:640-653.